Literature DB >> 27446470

Correlation between FOXP3 expression and gastric cancer.

Guoxiao Guo1, Zhikuan He1, Zhaohui Shi1.   

Abstract

The aim of the present study was to investigate the expression and function of forkhead box protein 3 (FOXP3) in gastric cancer using a rat model. A total of 92 Wistar rats were divided into two groups: An experimental group (n=46) and a control group (n=46). In the experimental group, sarcosine ethyl ester hydrochloride and sodium nitrite carcinogens were administered for 6 months to induce gastric cancer, whereas the control group was administered saline. Reverse transcription-polymerase chain reaction, immunoblotting, immunohistochemistry and western blotting were applied to analyze FOXP3 expression in gastric cancer and normal gastric tissue in the experimental and control groups, respectively. The association between FOXP3 expression and gastric cancer pathogenesis was investigated. In the experimental group, 6/46 rats developed hyperplastic lesions (grade I), 8 rats developed precancerous lesions (grade II), 18 rats developed early stage gastric cancer (grade III) and 14 rats developed gastrointestinal invasive carcinoma (grade IV). FOXP3 transcription and expression was observed in all gastric tissues of the experimental group. FOXP3 transcription and expression levels were significantly higher in the experimental group than in the control group (P<0.05). Furthermore, in the experimental group, a higher lesion grade was associated with a higher level of FOXP3 transcription and expression (P<0.05). FOXP3 protein was predominantly distributed in the tumor nuclei of the gastric cancer tissues. In the 32 pathological slices of gastric cancer tissue obtained from the experimental group, 20 cases (62.50%) exhibited positive FOXP3 staining. In the hyperplastic (grade I) and precancerous gastric (grade II) tissues, 2 cases (33.33%) and 4 cases (50.00%) exhibited positive FOXP3 staining, respectively. However, no positive FOXP3 expression was identified in the 46 pathological gastric tissue slices obtained from the control group. In conclusion, the expression of FOXP3 exhibits a positive correlation with gastric lesion grade. Therefore, FOXP3 may exhibit an important function in the occurrence and development of gastric cancer.

Entities:  

Keywords:  correlation; forkhead box protein 3; gastric carcinoma

Year:  2016        PMID: 27446470      PMCID: PMC4950068          DOI: 10.3892/ol.2016.4752

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Foxp3 gene polymorphisms and haplotypes associate with susceptibility of Graves' disease in Chinese Han population.

Authors:  Lei Zheng; XiaoBei Wang; Lijuan Xu; Ning Wang; Pengcheng Cai; Tao Liang; LiHua Hu
Journal:  Int Immunopharmacol       Date:  2015-02-21       Impact factor: 4.932

2.  A rising trend in the incidence of advanced gastric cancer in young Hispanic men.

Authors:  Shaila J Merchant; Joseph Kim; Audrey H Choi; Virginia Sun; Joseph Chao; Rebecca Nelson
Journal:  Gastric Cancer       Date:  2016-02-29       Impact factor: 7.370

3.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

Review 4.  [The Role of Regulatory T-cells in Antitumor Immune Response].

Authors:  M Klabusay
Journal:  Klin Onkol       Date:  2015

5.  Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Jean Rivier; Peter Kobelt; Hubert Mönnikes; Nils W G Lambrecht; Yvette Taché
Journal:  Endocrinology       Date:  2009-10-01       Impact factor: 4.736

6.  FOXP3 inhibits NF-κB activity and hence COX2 expression in gastric cancer cells.

Authors:  Qiang Hao; Cun Zhang; Yuan Gao; Shuning Wang; Jialin Li; Meng Li; Xiaochang Xue; Weina Li; Wei Zhang; Yingqi Zhang
Journal:  Cell Signal       Date:  2013-12-02       Impact factor: 4.315

7.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

Review 8.  Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation.

Authors:  Niloufar Safinia; Cristiano Scotta; Trishan Vaikunthanathan; Robert I Lechler; Giovanna Lombardi
Journal:  Front Immunol       Date:  2015-08-31       Impact factor: 7.561

9.  FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

Authors:  Tao Zuo; Lizhong Wang; Carl Morrison; Xing Chang; Huiming Zhang; Weiquan Li; Yan Liu; Yin Wang; Xingluo Liu; Michael W Y Chan; Jin-Qing Liu; Richard Love; Chang-Gong Liu; Virginia Godfrey; Rulong Shen; Tim H-M Huang; Tianyu Yang; Bae Keun Park; Cun-Yu Wang; Pan Zheng; Yang Liu
Journal:  Cell       Date:  2007-06-14       Impact factor: 41.582

10.  Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer.

Authors:  Y Mizukami; K Kono; Y Kawaguchi; H Akaike; K Kamimura; H Sugai; H Fujii
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

View more
  4 in total

1.  FOXP3 promotes colorectal carcinoma liver metastases by evaluating MMP9 expression via regulating S-adenosylmethionine metabolism.

Authors:  Zhe Wang; Jingdong Zhang
Journal:  Ann Transl Med       Date:  2020-05

2.  Transcriptional activation of Proteasome 26S non-ATPase subunit 7 by forkhead box P3 participates in gastric cancer cell proliferation and apoptosis.

Authors:  Yujie Xu; Dingmao Wang; Guodong Zhao
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

3.  Identification of DEGs and transcription factors involved in H. pylori-associated inflammation and their relevance with gastric cancer.

Authors:  Honghao Yin; Aining Chu; Songyi Liu; Yuan Yuan; Yuehua Gong
Journal:  PeerJ       Date:  2020-06-03       Impact factor: 2.984

4.  A new candidate oncogenic lncRNA derived from pseudogene WFDC21P promotes tumor progression in gastric cancer.

Authors:  Huaiping Cui; Zhaoyu Jiang; Shujie Zeng; Hao Wu; Zihao Zhang; Xiaobo Guo; Kangdi Dong; Jinshen Wang; Liang Shang; Leping Li
Journal:  Cell Death Dis       Date:  2021-10-02       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.